|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of intangible assets | |||||
| Stock-based compensation | |||||
| Impairment on intangibles | |||||
| Amortization of debt issue costs | |||||
| Deferred income tax benefit | |||||
| Loss on debt extinguishment | |||||
| Deferred taxes and impairment of property and equipment | |||||
| Loss on asset disposals | |||||
| Provision for inventory reserves | |||||
| Provision for bad debts | |||||
| Provision for credit losses | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Revenue earned but not billed | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue, current and long-term | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities | |||||
| Cash to fund acquisitions, net of cash received | |||||
| Cash paid for investment | |||||
| Purchase of property and equipment | |||||
| Additions to patents and licenses | |||||
| Proceeds from sales of property, plant and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Payment of long-term debt | |||||
| Proceeds from revolving credit facility | |||||
| Payments of revolving credit facility | |||||
| Proceeds from long-term debt | |||||
| Unamortized debt issuance cost write-off | |||||
| Issuance of treasury stock | |||||
| Proceeds from public stock offering, net of issuance costs | |||||
| Payments to settle employee tax withholdings on stock-based compensation | |||||
| Debt issue costs | |||||
| Proceeds from employee equity exercises | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Operating lease assets obtained in exchange for new operating lease liabilities | |||||
| Issuance of common stock to Final Frontier, LLC as partial payment of earnout obligation | |||||
| Issuance of subordinated debt for earnout obligation |
Loading...